Hypertrophy of colonic smooth muscle: structural remodeling, chemical composition, and force output.
The cellular basis of adaptations occurring during the development of megacolon was studied with the lethal spotted mouse model. Age-dependent changes in the length-force characteristics of the colon reach a steady state by 3-4 mo and include an increased relative force development at very short muscle lengths. In megacolon the following occur: 1) structural remodeling expressed as a greater increase in the fraction of maximum force production at short lengths, a shift of optimum length (Lo) to longer lengths, and no change in force per square centimeter; 2) hypertrophy and hyperplasia of both circular and longitudinal muscle; 3) high resting compliance consistent with no disproportionate change in collagen or elastin composition; 4) marked distension so that in situ circumference approximately 1.8 Lo, where active force production is low, and 5) slack length approximately 0.65 Lo, as in normal colon. Biochemical remodeling in megacolon includes disproportionate increases in ATP and phosphocreatine concentration, with 3.5-fold more preformed phosphagen than in normal colon. The myosin concentration is the same in both muscles, but the actin concentration is 1.5-fold greater in megacolon. Most of the cellular changes in megacolon would facilitate high active force output from the muscle at much larger intestinal diameters.
Siegman
M J
MJ
Department of Physiology, Jefferson Medical College, Philadelphia, Pennsylvania 19107, USA.
Butler
T M
TM
Mooers
S U
SU
Trinkle-Mulcahy
L
L
Narayan
S
S
Stirewalt
W S
WS
Starcher
B C
BC
D000199:Actins / Q000378:metabolism; D000227:Adenine Nucleotides / Q000378:metabolism*; D000375:Aging / Q000502:physiology*; D000818:Animals; D003094:Collagen / Q000378:metabolism; D003106:Colon / Q000473:pathology / Q000502:physiology / Q000503:physiopathology*; D003401:Creatine / Q000378:metabolism; D003404:Creatinine / Q000378:metabolism; D004549:Elastin / Q000378:metabolism; D004558:Electric Stimulation; D006579:Heterozygote; D006965:Hyperplasia; D006984:Hypertrophy; D066298:In Vitro Techniques; D007413:Intestinal Mucosa / Q000473:pathology / Q000502:physiology / Q000503:physiopathology; D008531:Megacolon / Q000235:genetics / Q000473:pathology / Q000503:physiopathology*; D051379:Mice; D008817:Mice, Mutant Strains; D009119:Muscle Contraction / Q000187:drug effects; D009130:Muscle, Smooth / Q000473:pathology / Q000502:physiology / Q000503:physiopathology*; D009218:Myosins / Q000378:metabolism; D011188:Potassium / Q000494:pharmacology
D000199:Actins; D000227:Adenine Nucleotides; D003094:Collagen; D004549:Elastin; D003404:Creatinine; D009218:Myosins; D003401:Creatine; D011188:Potassium